Role of Serum Calcium and Magnesium Estimation at 20–28 Weeks of Gestation in Prediction of Pregnancy-Induced Hypertension
摘要
Pregnancy-induced hypertension (PIH), a major contributor to global maternal morbidity and mortality, is a disorder marked by elevated blood pressure with or without end-organ damage. It is a condition unique to pregnancy that stems from abnormal uteroplacental development, and possibly, altered mineral homeostasis.
ObjectiveTo determine whether estimating serum calcium (Ca2+) and magnesium (Mg2+) levels in the late-second trimester can predict PIH later in pregnancy.
Material and MethodsIn this prospective cohort study, 225 normotensive gravid women underwent total serum Ca2+ and Mg2+ estimations between 20 and 28 weeks of gestation and at delivery. They were followed up until 48 h after delivery for the development of PIH (preeclampsia, gestational hypertension, eclampsia).
ResultsA total of 52 (23.11%) women developed PIH, of which 14 (6.22%) women had preeclampsia. Although mean (SD) (mg/dL) serum Ca2+ (8.79(0.38) vs. 8.78(0.38); p = 0.696) and Mg2+ (1.92(0.25) vs. 1.92(0.21); p = 0.669) levels decreased between the second trimester and delivery, levels remained consistently higher in women with PIH. The ROC-AUC of serum Mg2+ for predicting PIH and preeclampsia at 20–28 weeks of gestation was 0.577 (95%CI 0.509,0.642); p = 0.09) and 0.647 (95%CI 0.581,0.709; p = 0.041), respectively; for serum Ca2+, the values were 0.544 (95%CI 0.476,0.61; p = 0.359) and 0.558 (95%CI 0.491,0.62; p = 0.46), respectively. At a serum Mg2+(mg/dL) cut-off value of > 1.9, the sensitivity of predicting preeclampsia was 92.96%, with a NPV value of 98.3%.
ConclusionTotal serum Ca2+ and Mg2+ levels decrease from the second to third trimesters of pregnancy. A total serum Mg2+ level of > 1.9 mg/dL at 20–28 weeks of gestation is a relatively inexpensive screening tool that can fairly predict preeclampsia later in pregnancy.